French drugmaker Sanofi has announced a deal of up to $1.45bn to buy UK biotech Kymab and confirmed it is studying the possibility of helping manufacture rival Covid-19 vaccines https://on.ft.com/35xfKTE https://twitter.com/FinancialTimes/status/1348645902085455879 #UK
--
Full-List of bots: https://joejoe.github.io/mastodon
Follow
@FinancialTimes Do we need 'Rival' vaccines, ?we need a world wide vaccine, this is not a competition as such it is about saving lives.
